Three Times Oversubscribed: Kirkland Advises ARCHIMED on €1.5B MED IV
Kirkland & Ellis has advised healthcare-focused private equity firm ARCHIMED on the final close of MED IV at its €1.5 billion ($1.75 billion) hard cap, well above the original €1.2 billion target.
Kirkland & Ellis
·
·
1 min read

Kirkland & Ellis has advised healthcare-focused private equity firm ARCHIMED on the final close of MED IV at its €1.5 billion ($1.75 billion) hard cap, well above the original €1.2 billion target. The fund launched in January 2026 and closed in under six months, three times oversubscribed, with strong demand from existing and new investors.
The Kirkland team was led by Raphaël Bloch, Richard Watkins, Christopher Braunack and Sebastien Clisson.
Share
More in Fund Raises
Newsletter
Subscribe to Market Insights
The IFLD newsletter on the investment funds legal market, sent by email.




